Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 14, 2014 - Issue 6
Submit an article Journal homepage
521
Views
10
CrossRef citations to date
0
Altmetric
Drug Evaluations

Certolizumab pegol in rheumatoid arthritis: current update

Marie FechtenbaumUniversity of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK+44 113 3924884; +44 113 3924991; [email protected];Leeds Teaching Hospitals NHS Trust, NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK
, MD MSc,
Md Yuzaiful Md YusofUniversity of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK+44 113 3924884; +44 113 3924991; [email protected];Leeds Teaching Hospitals NHS Trust, NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK
, MBChB MRCP &
Paul EmeryUniversity of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK+44 113 3924884; +44 113 3924991; [email protected];Leeds Teaching Hospitals NHS Trust, NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK
, MA MD FRCP FRCPE
Pages 841-850 | Published online: 22 Mar 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Marie Fournier, Chieh-I Chen, Andreas Kuznik, Clare Proudfoot, Usha G Mallya & Kaleb Michaud. (2019) Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patient. ClinicoEconomics and Outcomes Research 11, pages 117-128.
Read now
Priyanka Vashisht & James O’dell. (2017) Not all TNF inhibitors in rheumatoid arthritis are created equal: important clinical differences. Expert Opinion on Biological Therapy 17:8, pages 989-999.
Read now
Andrea Matucci, Daniele Cammelli, Fabrizio Cantini, Delia Goletti, Valentina Marino, Giuseppe Maria Milano, Raffaele Scarpa, Giuliano Tocci, Enrico Maggi & Alessandra Vultaggio. (2016) Influence of anti-TNF immunogenicity on safety in rheumatic disease: a narrative review. Expert Opinion on Drug Safety 15:sup1, pages 3-10.
Read now
Francis Fagnani, Thao Pham, Pascal Claudepierre, Francis Berenbaum, Thibault De Chalus, Carine Saadoun, Jean-Michel Joubert & Bruno Fautrel. (2016) Modeling of the clinical and economic impact of a risk-sharing agreement supporting a treat-to-target strategy in the management of patients with rheumatoid arthritis in France. Journal of Medical Economics 19:8, pages 812-821.
Read now
Jacqueline Detert & Pascal Klaus. (2015) Biologic monotherapy in the treatment of rheumatoid arthritis. Biologics: Targets and Therapy 9, pages 35-43.
Read now
Renata Baronaite Hansen & Arthur Kavanaugh. (2015) Certolizumab pegol for the treatment of psoriatic arthritis. Expert Review of Clinical Immunology 11:3, pages 307-318.
Read now
Hideaki Nakamura, Fang Jun & Hiroshi Maeda. (2015) Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls. Expert Opinion on Drug Delivery 12:1, pages 53-64.
Read now

Articles from other publishers (3)

Piercarlo Sarzi-Puttini, Emilio Filippucci, Silvano Adami, Pier Luigi Meroni, Alberto Batticciotto, Luca Idolazzi, Orazio De Lucia, Pablo Talavera, Thomas Kumke & Walter Grassi. (2018) Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED Study. Advances in Therapy 35:8, pages 1153-1168.
Crossref
J. Herrerias-Moreno, V. Expósito-Serrano, E. Agut-Busquet, M. Corbacho, E. Sáez & J. Luelmo. (2018) Cutaneous leishmaniasis mimicking dactylitis in a patient with rheumatoid arthritis treated with certolizumab. Clinical and Experimental Dermatology 43:3, pages 348-350.
Crossref
Gene-Siew Ngian, Andrew M. Briggs, Ilana N. Ackerman & Sharon Van Doornum. (2016) Safety of anti-rheumatic drugs for rheumatoid arthritis in pregnancy and lactation. International Journal of Rheumatic Diseases 19:9, pages 834-843.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.